A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

The Stanford School of Medicine launched the REACH Initiative to boost representation in medicine and reduce health inequities among minority populations.

Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.

Over-reporting of Black children and under-reporting of white children as suspected abuse victims suggests systemic bias from medical providers, Stanford Medicine research shows.

Renee Wegrzyn, who leads the Advanced Research Projects Agency for Health, discussed the agency’s plan to accelerate better health outcomes for everyone.

Cells in the adult liver were thought to divide rarely. But a study led by Stanford Medicine researchers found intermittent fasting causes rapid cell division.

In a mouse study led by Stanford Medicine scientists, a drug made mammalian pain receptors more like those in birds — and more resistant to some forms of pain.

Telomeres shorten in heart muscle cells from people with Duchenne muscular dystrophy. A Stanford Medicine study finds blocking this process improves the health of these cells grown in a dish.

A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.

Neutrophils often suppress the immune system’s response to cancer, but when activated, they eliminate several types of tumors in laboratory mice, a study led by Stanford Medicine has found.

The new issue of Stanford Medicine magazine features articles about the ways nonmedical factors can help or hinder our health and presents initiatives to promote health equity.

Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.